These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33840052)

  • 21. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
    Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinsonian syndrome in familial frontotemporal dementia.
    Siuda J; Fujioka S; Wszolek ZK
    Parkinsonism Relat Disord; 2014 Sep; 20(9):957-64. PubMed ID: 24998994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
    van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frontotemporal dementias].
    Witt K; Deuschl G; Bartsch T
    Nervenarzt; 2013 Jan; 84(1):20-32. PubMed ID: 22366755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frontotemporal Lobar Degeneration.
    Premi E; Padovani A; Borroni B
    Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on genetic frontotemporal dementia.
    Greaves CV; Rohrer JD
    J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal dementia.
    Bang J; Spina S; Miller BL
    Lancet; 2015 Oct; 386(10004):1672-82. PubMed ID: 26595641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia.
    Convery R; Mead S; Rohrer JD
    Neuropathol Appl Neurobiol; 2019 Feb; 45(1):6-18. PubMed ID: 30582889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.
    Gazzina S; Archetti S; Alberici A; Bonomi E; Cosseddu M; Di Lorenzo D; Padovani A; Borroni B
    J Alzheimers Dis; 2017; 57(4):1185-1189. PubMed ID: 28304311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.
    Fujioka S; Wszolek ZK
    J Mol Neurosci; 2011 Nov; 45(3):359-65. PubMed ID: 21656039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.
    Mackenzie IR; Neumann M
    J Neurochem; 2016 Aug; 138 Suppl 1():54-70. PubMed ID: 27306735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review.
    Valente ES; Caramelli P; Gambogi LB; Mariano LI; Guimarães HC; Teixeira AL; de Souza LC
    Alzheimers Res Ther; 2019 Apr; 11(1):30. PubMed ID: 30935398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Study of Patients With C9ORF72-Associated Frontotemporal Dementia Presenting With Delusions.
    Shinagawa S; Naasan G; Karydas AM; Coppola G; Pribadi M; Seeley WW; Trojanowski JQ; Miller BL; Grinberg LT
    J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):99-107. PubMed ID: 25342578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What we know about TMEM106B in neurodegeneration.
    Nicholson AM; Rademakers R
    Acta Neuropathol; 2016 Nov; 132(5):639-651. PubMed ID: 27543298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of disease modifying drugs for dementia-focusing on anti-tau drugs-].
    Soeda Y; Takashima A
    Rinsho Shinkeigaku; 2014; 54(12):1178-80. PubMed ID: 25672738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The molecular pathology of frontotemporal lobar degeneration].
    Fujishiro H; Hasegawa M; Arai T
    Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.